Chairman
Dr Chris Hand has 30 years experience in the medical diagnostics industry in the development and commercialisation of in vitro diagnostic products.
Chief Executive Officer
Chris Yates co-founded Abingdon Health with Dr Chris Hand and Dr Brett Pollard in 2008 and was a non-executive of the Company prior to his appointment as CEO in 2015.
Finance Director
Richard Marlow joined Abingdon Health as Finance Director in October 2012. Prior to that, Richard spent 16 years at leading business advisory firm, Deloitte.
Operations Director
Michael was appointed Commercial Operations Director following over 25 years of experience in operational roles in the healthcare industry.
QARA Director
Marsha Leeman joined Abingdon Health in April 2014 with over 15 years’ experience in quality management, regulatory affairs and compliance management in the medical diagnostic industry.
Chief Technology Officer
David joined Abingdon Health in April 2017 and brings many years of experience in the identification, evaluation, development and commercialisation of novel and challenging immunoassays.
Sales and Marketing Director
Appointed as Head of Sales and Marketing in November 2015, Fiona brings many years commercial experience of hematology oncology diagnostic products.
Non-Executive Director
James Wilkie joined the University of Birmingham in early 2007 and is currently CEO of Alta Innovations Ltd.
Non-executive Director
Simon Cartmell OBE is Operating Partner for Imperial Innovations, a publically listed technology investment business.
Non-executive Director
Max Duckworth is an independent investor focusing on early-stage opportunities across several different sectors, including healthcare and technology.
Senior R&D Consultant
Dene has 30 years of experience in the development, manufacture and commercialisation of immunodiagnostics.
© Abingdon Health 2017
